151 related articles for article (PubMed ID: 20505648)
21. Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.
Keil F; Daikos GL; Skoutelis A; Dominguez JI; Pathan R; Hamed K
Adv Ther; 2015 Aug; 32(8):715-26. PubMed ID: 26239201
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation.
Sakoulas G
Clin Microbiol Infect; 2009 Dec; 15 Suppl 6():11-6. PubMed ID: 19917022
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
[TBL] [Abstract][Full Text] [Related]
24. Clinical experience with daptomycin treatment of foot or ankle osteomyelitis: a preliminary study.
Holtom PD; Zalavras CG; Lamp KC; Park N; Friedrich LV
Clin Orthop Relat Res; 2007 Aug; 461():35-9. PubMed ID: 17549028
[TBL] [Abstract][Full Text] [Related]
25. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
Pertel PE; Bernardo P; Fogarty C; Matthews P; Northland R; Benvenuto M; Thorne GM; Luperchio SA; Arbeit RD; Alder J
Clin Infect Dis; 2008 Apr; 46(8):1142-51. PubMed ID: 18444848
[TBL] [Abstract][Full Text] [Related]
26. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
Arbeit RD; Maki D; Tally FP; Campanaro E; Eisenstein BI;
Clin Infect Dis; 2004 Jun; 38(12):1673-81. PubMed ID: 15227611
[TBL] [Abstract][Full Text] [Related]
27. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S
Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
Segreti JA; Crank CW; Finney MS
Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of daptomycin in complicated skin and soft-tissue infections and bacteraemia in clinical practice: results of a large non-interventional study.
Gonzalez-Ruiz A; Beiras-Fernandez A; Lehmkuhl H; Dohmen PM; Loeffler J; Chaves RL
Int J Antimicrob Agents; 2013 Apr; 41(4):372-8. PubMed ID: 23499225
[TBL] [Abstract][Full Text] [Related]
30. [The EUCORE registry: objectives and general results].
Cercenado E; Pachón J
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():3-9. PubMed ID: 22541969
[TBL] [Abstract][Full Text] [Related]
31. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
[TBL] [Abstract][Full Text] [Related]
32. Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections.
Finney MS; Crank CW; Segreti J
Curr Med Res Opin; 2005 Dec; 21(12):1923-6. PubMed ID: 16368041
[TBL] [Abstract][Full Text] [Related]
33. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
34. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
Mave V; Garcia-Diaz J; Islam T; Hasbun R
J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
[TBL] [Abstract][Full Text] [Related]
37. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
Mergenhagen KA; Pasko MT
Ann Pharmacother; 2007 Sep; 41(9):1531-5. PubMed ID: 17652126
[TBL] [Abstract][Full Text] [Related]
38. Cubicin Outcomes Registry and Experience (CORE) methodology.
Rolston KV; Segreti J; Lamp KC; Friedrich LV
Am J Med; 2007 Oct; 120(10 Suppl 1):S4-5. PubMed ID: 17904949
[TBL] [Abstract][Full Text] [Related]
39. Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis.
Bliziotis IA; Plessa E; Peppas G; Falagas ME
Ann Pharmacother; 2010 Jan; 44(1):97-106. PubMed ID: 19934396
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
Kullar R; McClellan I; Geriak M; Sakoulas G
Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
